English
  • Crisaborole

    Crisaborole

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Crisaborole Atopic Dermatitis and Eczema Pfizer Jun. 11, 2026 
    inquirydetail
  • Canagliflozin

    Canagliflozin

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Canagliflozin Type 2 diabetes In-House √    
    inquirydetail
  • Chlorothiazide

    Chlorothiazide

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Chlorothiazide Diuretics USP/EP      
    inquirydetail
  • Captopril

    Captopril

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Captopril Hypertension USP/EP √ √  
    inquirydetail